NME https://www.bioworld.com/rss en-us NME Digest: Q4 2025 http://www.bioworld.com/articles/729008 Fri, 13 Feb 2026 09:00:00 -0500 https://www.bioworld.com/articles/729008-nme-digest-q4-2025 Jascayd for idiopathic pulmonary fibrosis among 20 October US nods http://www.bioworld.com/articles/726336 Fri, 21 Nov 2025 12:00:00 -0500 https://www.bioworld.com/articles/726336-jascayd-for-idiopathic-pulmonary-fibrosis-among-20-october-us-nods FDA Approved seal NME Digest: Q3 2025 http://www.bioworld.com/articles/725816 Tue, 04 Nov 2025 08:00:00 -0500 https://www.bioworld.com/articles/725816-nme-digest-q3-2025 US FDA adds five NMEs in August, led by Brinsupri and Modeyso BioWorld for the period, after 2024’s high of 159.]]> http://www.bioworld.com/articles/724313 Fri, 19 Sep 2025 11:00:00 -0400 https://www.bioworld.com/articles/724313-us-fda-adds-five-nmes-in-august-led-by-brinsupri-and-modeyso FDA Approved stamp with pills, bottle, blister pack US FDA approves six NMEs in July; Kalvista, PTC, Regeneron rise BioWorld’s records, trailing 135 approvals in 2024 and 126 in 2020.]]> http://www.bioworld.com/articles/723660 Tue, 26 Aug 2025 11:00:00 -0400 https://www.bioworld.com/articles/723660-us-fda-approves-six-nmes-in-july-kalvista-ptc-regeneron-rise US FDA approves six NMEs in July; Kalvista, PTC, Regeneron rise BioWorld’s records, trailing 135 approvals in 2024 and 126 in 2020.]]> http://www.bioworld.com/articles/723289 Fri, 22 Aug 2025 11:00:00 -0400 https://www.bioworld.com/articles/723289-us-fda-approves-six-nmes-in-july-kalvista-ptc-regeneron-rise NME Digest: Q2 2025 Contact us to upgrade your account.]]> http://www.bioworld.com/articles/722787 Mon, 04 Aug 2025 11:00:00 -0400 https://www.bioworld.com/articles/722787-nme-digest-q2-2025 NME Digest: Q2 2025 http://www.bioworld.com/articles/722897 Mon, 04 Aug 2025 09:00:00 -0400 https://www.bioworld.com/articles/722897-nme-digest-q2-2025 Investigation into questionable investments prompts executive re-shuffle at China’s Cstone http://www.bioworld.com/articles/519484 Tue, 07 Jun 2022 12:00:00 -0400 https://www.bioworld.com/articles/519484-investigation-into-questionable-investments-prompts-executive-re-shuffle-at-chinas-cstone Investigation into questionable investments prompts executive re-shuffle at China’s Cstone http://www.bioworld.com/articles/519389 Thu, 02 Jun 2022 12:00:00 -0400 https://www.bioworld.com/articles/519389-investigation-into-questionable-investments-prompts-executive-re-shuffle-at-chinas-cstone BIO 2020 – BIO 2021: From then to now, industry remains robust as BIO Digital 2021 kicks off http://www.bioworld.com/articles/508012 Wed, 09 Jun 2021 12:00:00 -0400 https://www.bioworld.com/articles/508012-bio-2020-bio-2021-from-then-to-now-industry-remains-robust-as-bio-digital-2021-kicks-off Virtual meetings illustration Biopharma sector scores the approval of 48 new medicines in 2019 http://www.bioworld.com/articles/432122 Tue, 31 Dec 2019 12:00:00 -0500 https://www.bioworld.com/articles/432122-biopharma-sector-scores-the-approval-of-48-new-medicines-in-2019 Pill over molecule structures